Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure

26 May 2019 (08:43 - 08:53)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Patrick Rossignol

The Princess Grace Hospital Centre, Monaco (Monaco)

12 More presentations in this session

Presentation thumbnail

Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial

Professor M. Schulz (Leipzig, DE)

Presentation thumbnail

Discussion - PHARM-CHF

Presentation thumbnail

Discussion - AMBER.

Presentation thumbnail

Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

Doctor A. Biolo (Porto Alegre, BR)

Presentation thumbnail

Discussion - Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

Access the full session

Session thumbnail

Late breaking trial II - Chronic heart failure

The Event

Heart Failure 2019

26 May 2019 08:43 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources